Skip to content

Implementation of a Very Low Calorie Diet for Remission of Type 2 Diabetes in the Community

Implementation of a Very Low Calorie Diet for Remission of Type 2 Diabetes in the Community

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03536377
Enrollment
100
Registered
2018-05-24
Start date
2019-02-11
Completion date
2020-12-31
Last updated
2019-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2 in Obese

Keywords

Diabetes Mellitus Remission, Prediabetic State, caloric restriction, weight loss, diet, Barbados

Brief summary

The complications associated with uncontrolled type-2 diabetes mellitus (T2DM) are numerous; reducing the quality of life for the patient and consuming a considerable portion of healthcare finances. The Health of the Nation (HotN) 2011 study reported that 50% of the Barbadian population \>65years old had a diagnosis of T2DM and that two-thirds of the population were overweight - which is a risk factor for the development of T2DM. Encouraged by the success of the Counterpoint study in the United Kingdom (UK), the Barbados Diabetes Reversal Study 1 (BDRS1) was established using a similar protocol; the aim of which was to evaluate the feasibility of implementing a very low calorie diet to reverse T2DM in Barbados. At the end of the 8-week intervention period, the 25 participants had achieved an average weight loss of 10.1kg (22lbs). This was accompanied by an increase in the number of participants whose fasting blood sugars were now within normal range despite being off of their diabetes medication; and a decrease in the number of participants taking blood pressure medication. Participants transitioned to a solid diet over a 4-week period, with guidance on health dietary habits and regular exercise routines. The benefits accrued during the intervention phase were preserved at the end of the transition period. We now propose the Barbados Diabetes Remission Study 2 (BDRS2) as a sustainable community intervention - utilizing the local church as the community site. We hypothesize that this will enhance reach while reducing the cost of the study and will also facilitate the structures necessary for the social support of the participant.

Interventions

OTHERvery low calorie liquid diet

Phase 1: very low calorie liquid formulation Phase 2: Nutritionally balanced solid diet Phase 3: Educational material

Sponsors

The University of The West Indies
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 20 - 70 years old, all ethnicities * Diagnosis of T2DM for \<6 years as defined by the American Diabetes Association * Diagnosis of pre-diabetes as defined by the American Diabetes Association * Body Mass index (BMI) of 27 kg/m2 and over

Exclusion criteria

* Insulin use * Substance abuse * Current cancer diagnosis * myocardial infarction within last 6 month * learning difficulties * current treatment with anti-obesity drugs * diagnosed eating disorder or purging * HbA1c \> 10% * pregnant/considering pregnancy * evidence of liver disease (including liver enzymes \> 3 times above normal values) * evidence of renal disease (creatinine of \> 150 mmol/l) * persons who have required hospitalisation for depression, or are on antipsychotic drugs

Design outcomes

Primary

MeasureTime frame
change in weightenrolment, 12 weeks, 6 mths and 1 year
change in fasting glucoseEnrolment, 12 weeks, 6 months, 1 year
change in Hba1CEnrolment, 12 weeks, 6 months, 1 year

Secondary

MeasureTime frameDescription
change in blood pressure medicationweekly for the first 12 weeks
change in waist circumferenceEnrolment, 12 weeks, 6 months, 1 year
change in blood pressureEnrolment, 12 weeks, 6 months, 1 yearboth the systolic and diastolic pressures will be measured

Countries

Barbados

Contacts

Primary ContactKim R Quimby, MBBS, PhD
kim.quimby@cavehill.wui.edu12464266416

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026